Health Insurance - Workgroup to Study the Definition of Specialty Drug
Hearing (House)
Email me when HB 1469 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 1469. By continuing you agree to the Terms and Privacy Policy.
Summary
The Maryland Insurance Administration must convene a workgroup that includes pharmacy‑benefit managers, independent pharmacists, insurers, a managed‑care organization, a hospital and another health‑care provider. The group will examine the current specialty‑drug definition, assess its impact on patients and other stakeholders, compare it to definitions used elsewhere, and propose a new definition. Their findings are to be reported to the governor and General Assembly, and the law ends on June 30 2027.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 1469
3 free questions a day, no accountHearings
- Health — Bill HearingHealth · Mar 12, 2026
History
- Hearing 3/12 at 1:00 p.m.
- First Reading Health
Sponsors
- Cullison · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 1469 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1469 freeOr ask your AI assistant about HB 1469 directly:
Add to Claude, ChatGPT or Cursor